Literature DB >> 8177390

Venous thromboembolism in neurosurgery and neurology patients: a review.

M G Hamilton1, R D Hull, G F Pineo.   

Abstract

Thromboembolism is a common problem in neurosurgery and neurology patients. Within this diverse population are subpopulations of patients with varying degrees of thromboembolic risk: low, moderate, and high. Patients at substantial risk for deep vein thrombosis and pulmonary embolism include those with spinal cord injury, brain tumor, subarachnoid hemorrhage, head trauma, stroke, and patients undergoing a neurosurgical operation. There are prophylactic strategies that can be applied to these various risk groups that will dramatically reduce the incidence of thromboembolism. The risk of pulmonary embolism or fatal pulmonary embolism typically exceeds the risk of severe or fatal bleeding from adequate prophylaxis, and these techniques should be applied on a routine basis. To adequately care for patients with deep venous thrombosis and pulmonary embolism, the physician requires a thorough understanding of the methods of diagnosis, the pharmacokinetics of heparin and warfarin, and a knowledge of their role in the treatment strategies that have proven efficacy and safety. In addition, an awareness of the low molecular weight heparins and heparinoids is becoming essential. These new agents have a potentially promising role in both the prophylaxis and treatment of patients with neurological disease. The principles concerning the prophylaxis, diagnosis, and clinical management of venous thromboembolic disease in neurosurgery and neurology patients are dealt with in this review.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8177390     DOI: 10.1227/00006123-199402000-00012

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  29 in total

1.  Incidence of Deep Vein Thrombosis in Patients Undergoing Degenerative Spine Surgery onProphylactic Dalteparin; A Single Center Report.

Authors:  AlirezaFarid Moayer; Navideh Mohebali; Ali Razmkon
Journal:  Bull Emerg Trauma       Date:  2016-01

2.  Incidence of venous thromboembolism in hospitalized pediatric neurosurgical patients: a retrospective 25-year institutional experience.

Authors:  Mason A Brown; Daniel H Fulkerson
Journal:  Childs Nerv Syst       Date:  2019-11-05       Impact factor: 1.475

3.  Venous Thromboembolism during Interventional MRI-Guided Stereotactic Surgery.

Authors:  Adam J Kundishora; Dario J Englot; Philip A Starr; Alastair J Martin; Paul S Larson
Journal:  Stereotact Funct Neurosurg       Date:  2018-03-01       Impact factor: 1.875

4.  Predictors of Venous Thromboembolism After Nonemergent Craniotomy: A Nationwide Readmission Database Analysis.

Authors:  Ian A Buchanan; Michelle Lin; Daniel A Donoho; Arati Patel; Li Ding; Arun P Amar; Steven L Giannotta; William J Mack; Frank Attenello
Journal:  World Neurosurg       Date:  2018-11-20       Impact factor: 2.104

5.  Symptomatic venous thromboembolism: incidence and risk factors in patients with spontaneous or traumatic intracranial hemorrhage.

Authors:  Keri S Kim; Gretchen M Brophy
Journal:  Neurocrit Care       Date:  2009-02-24       Impact factor: 3.210

6.  Inferior vena cava filters for primary prophylaxis: when are they indicated?

Authors:  Eric Wehrenberg-Klee; S William Stavropoulos
Journal:  Semin Intervent Radiol       Date:  2012-03       Impact factor: 1.513

7.  Impact of practice change in reducing venous thromboembolism in neurocritical overweight patients: 2008-2014.

Authors:  Sophie Samuel; Suhas Bajgur; Jude P Savarraj; Huimahn A Choi
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

8.  Venous thromboembolism prophylaxis after head and spinal trauma: intermittent pneumatic compression devices versus low molecular weight heparin.

Authors:  Mehmet Kurtoglu; Hakan Yanar; Yilmaz Bilsel; Recep Guloglu; Sevda Kizilirmak; Dincay Buyukkurt; Volkan Granit
Journal:  World J Surg       Date:  2004-08-03       Impact factor: 3.352

9.  Incidental internal jugular vein thrombosis in a patient with intracranial aneurysm: Implications for the anesthesiologists.

Authors:  Georgene Singh; Arimanickam Ganesamoorthi; Sethuraman Manikandan; Ramesh C Rathod
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2013-04

10.  Effect of dalteparin and radiation on survival and thromboembolic events in glioblastoma multiforme: a phase II ECOG trial.

Authors:  H Ian Robins; Anne O'Neill; Mark Gilbert; Mark Olsen; Ronald Sapiente; Brian Berkey; Minesh Mehta
Journal:  Cancer Chemother Pharmacol       Date:  2007-09-20       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.